No Data
Guanhao Biotech (300238.SZ): Appointed Zhao Feng as General Manager.
On January 10, Guanhao Biotech (300238.SZ) announced that the Board of Directors recently received the resignation letter submitted by Mr. Zhang Yongming. To better fulfill the responsibilities of the Chairman, Mr. Zhang Yongming is applying to resign from the position of General Manager to devote more energy to the company's Global Strategy and governance. After resigning, Mr. Zhang Yongming will continue to serve as the Chairman of the Sixth Board of Directors, Chairman of the Strategic Committee, member of the Nomination Committee, and member of the Compensation and Assessment Committee. The company held the eleventh meeting of the Sixth Board of Directors on January 10, 2025, to review and approve the appointment of the company’s general manager.
Is Guanhao Biotech Co.,Ltd.'s (SZSE:300238) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
guanhao biotech (300238.SZ): the company has temporarily suspended the CAR-T project
On November 4th, Guanhao Biotech (300238.SZ) stated on the investor interaction platform that the company has temporarily suspended the CAR-T project.
Guan Hao Biology: Report for the third quarter of 2024
Guanhao Biotech (300238.SZ) released its performance for the first three quarters, with a net income of 27.8363 million yuan, a decrease of 32.55%.
guanhao biotech (300238.SZ) released the third quarter report for 2024, the company's revenue for the first three quarters of the year was 2...
Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 39% Price Boost Is Out Of Tune With Revenues
Guanhao BiotechLtd (SZSE:300238) Delivers Shareholders Notable 7.1% CAGR Over 5 Years, Surging 12% in the Last Week Alone
